The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Receptor-Defined Subtypes of Breast Cancer in Indigenous Populations in Africa: A Systematic Review and Meta-Analysis
|
---|---|
Published in |
PLOS Medicine, September 2014
|
DOI | 10.1371/journal.pmed.1001720 |
Pubmed ID | |
Authors |
Amanda Eng, Valerie McCormack, Isabel dos-Santos-Silva |
Abstract |
Breast cancer is the most common female cancer in Africa. Receptor-defined subtypes are a major determinant of treatment options and disease outcomes but there is considerable uncertainty regarding the frequency of poor prognosis estrogen receptor (ER) negative subtypes in Africa. We systematically reviewed publications reporting on the frequency of breast cancer receptor-defined subtypes in indigenous populations in Africa. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 17% |
Unknown | 5 | 83% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 50% |
Practitioners (doctors, other healthcare professionals) | 3 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 138 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | <1% |
Yemen | 1 | <1% |
Unknown | 136 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 29 | 21% |
Researcher | 19 | 14% |
Student > Ph. D. Student | 17 | 12% |
Student > Bachelor | 13 | 9% |
Student > Postgraduate | 11 | 8% |
Other | 25 | 18% |
Unknown | 24 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 57 | 41% |
Biochemistry, Genetics and Molecular Biology | 17 | 12% |
Nursing and Health Professions | 7 | 5% |
Agricultural and Biological Sciences | 6 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 3% |
Other | 16 | 12% |
Unknown | 31 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 September 2014.
All research outputs
#2,863,601
of 25,373,627 outputs
Outputs from PLOS Medicine
#2,964
of 5,162 outputs
Outputs of similar age
#29,658
of 249,804 outputs
Outputs of similar age from PLOS Medicine
#52
of 69 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,162 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 77.7. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 249,804 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 69 others from the same source and published within six weeks on either side of this one. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.